Evidence map›Paper›PMID 39753118›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Epidemiological Features of Sinonasal Adenocarcinoma and Prognostic Nomogram: A Study Based on the SEER Database.

Lu Yang, Yufeng Gu, Lei Yu, Qiang Zhou, Li Liu, Ying Mao, Ji Ma, Yong Li, Na Li

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lu YangDepartment of Oncology, Suining Central Hospital, Suining, China.ORCID 0000-0001-9566-6259
Yufeng GuDepartment of Oncology, Suining Central Hospital, Suining, China.
Lei YuDepartment of Oncology, The First People's Hospital of Guangyuan, Guangyuan, China.
Qiang ZhouDepartment of Oncology, Suining Central Hospital, Suining, China.
Li LiuDepartment of Oncology, Suining Central Hospital, Suining, China.
Ying MaoDepartment of Oncology, Suining Central Hospital, Suining, China.
Ji MaDepartment of Oncology, Suining Central Hospital, Suining, China.
Yong LiDepartment of Oncology, Suining Central Hospital, Suining, China.
Na LiDepartment of Oncology, Suining Central Hospital, Suining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOur study aimed to update demographic profiles of sinonasal adenocarcinoma (SNAC) between 2000 and 2020, identify independent prognostic risk factors, and devise a predictive nomogram for overall survival (OS).

methodsUtilizing the Surveillance, Epidemiology, and End Results (SEER) database, cases of SNAC from 2000 to 2020 were analyzed for incidence trends. Univariate and multivariate Cox regression models helped pinpoint factors impacting patient survival. A prognostic nomogram was then created based on these factors and assessed via concordance index, ROC analysis, and calibration curves.

resultsAnalysis of 488 SNAC patients indicated a rising incidence, peaking among 60-69-year-olds, with a male predominance and the highest occurrence in White populations. Common sites of occurrence included the nasal cavity, and the maxillary and ethmoid sinuses. The nomogram, developed with 184 patients, highlighted older age (≥70), male sex, advanced T stages (T4b, T4a), distant metastasis, larger tumors (≥5 cm), and lack of surgery as poor prognostic indicators. Nomogram performance demonstrated strong predictive capabilities in both training and validation cohorts.

conclusionThis investigation, leveraging the SEER database, elucidates the epidemiology of SNAC and pinpoints key adverse prognostic determinants: age ≥70, male gender, T stages T4b and T4a, presence of distant metastasis, tumor size exceeding 5 cm, and absence of surgical intervention. Moreover, it introduces a novel nomogram capable of accurately forecasting 1-, 3-, and 5-year OS for SNAC patients, thereby enhancing disease comprehension and facilitating the formulation of tailored therapeutic strategies by clinicians.

Indexed as

AdenocarcinomaNomogramsParanasal Sinus NeoplasmsSEER ProgramAdultAgedFemaleHumansIncidenceMaleMiddle AgedNeoplasm StagingPrognosisRisk FactorsUnited Statesepidemiologyprognosisrisk factorsinonasal adenocarcinomatreatments

Identifiers

PMID39753118
PMCPMC11700412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.